Cathy Wagner

机构：National Institutes of Health, National Cancer Institute, Center for Cancer Research

发表论文 6 篇 · 总被引 136 次 · h-index 5

代表论文

• Phase 2 Study of Olaparib in Malignant Mesothelioma and Correlation of Efficacy With Germline or Somatic Mutations in BAP1 Gene (2021 · JTO Clinical and Research Reports · 被引 57)
• Feasibility and preliminary safety and efficacy of first-in-human intraperitoneal delivery of MCY-M11, anti-human-mesothelin CAR mRNA transfected into peripheral blood mononuclear cells, for ovarian cancer and malignant peritoneal mesothelioma. (2020 · Journal of Clinical Oncology · 被引 33)
• Phase II study of olaparib in malignant mesothelioma (MM) to correlate efficacy with germline and somatic mutations in DNA repair genes. (2020 · Journal of Clinical Oncology · 被引 22)
• Multiple Onychopapillomas and BAP1 Tumor Predisposition Syndrome (2024 · JAMA Dermatology · 被引 17)
• Meningiomas in Patients With Malignant Pleural Mesothelioma Harboring Germline BAP1 Mutations (2021 · Journal of Thoracic Oncology · 被引 7)
• LB906 Multiple onychopapillomas are associated with BAP1 tumor predisposition syndrome (2024 · Journal of Investigative Dermatology)